Oral Wegovy Breakthrough: Revolutionary Weight Loss Drug Expands Treatment Horizons for Obesity and Metabolic Health
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Oral Wegovy Breakthrough: Revolutionary Weight Loss Drug Expands Treatment Horizons for Obesity and Metabolic Health
-
Narrated by:
-
By:
About this listen
Discover how Wegovy (semaglutide) is transforming healthcare beyond weight management in this comprehensive episode. Host Alexandra Reeves explores Novo Nordisk's groundbreaking FDA application for an oral Wegovy pill that could eliminate injection barriers by 2026, promising 13% weight loss without needles. Learn how this GLP-1 medication is reshaping treatment approaches for obesity, metabolic conditions, and surprisingly, liver health through the ESSENCE trial results for MASH (metabolic dysfunction-associated steatohepatitis). The episode also covers recent developments in insurance coverage, supply chain improvements, WeightWatchers' strategic pivot to medication management, and emerging research suggesting potential benefits against colon cancer. Join us for an evidence-based look at how this revolutionary treatment is creating a new paradigm in chronic disease management worldwide.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.